Abstract
Twenty years after the initial culture of HP, there has been a substantial change in the finding and treatment of upper gastroduodenal disease. A growing number of stomach cancers are caused by Helicobacter pylori infection, and researchers are also looking into how this infection affects other upper gastric tract inflammation. There has been significant progress in our understanding of the pathogenesis of this infection. Although there are powerful anti-microbial medications on the market, there is still no perfect treatment and the therapeutic indications are constantly evolving. Following the discovery of an HP infection, the clinician assesses the patient's clinical condition to determine whether therapy is necessary. Typically, HP eradication is suggested for the treatment and prevention of the infection. The microorganism that is introduced into the human stomach cancer that develops in the gastrointestinal tract causes the HP disease. In addition to gastrointestinal issues like belching, bloating, vomiting, indigestion, and constipation, it has been used for a long time to treat a variety of disorders. The purpose of the current study's findings was to assess how supplementing with ginger powder affected patients who had the HP infection's eradication and the relief of their dyspeptic symptoms.
Publisher
CrossLinks International Publishers
Reference44 articles.
1. Helicobacter pylori the possible role of in gastric cancer and its management;Alfarouk;Frontiers in Oncology,2019
2. 2. Centers for Disease Control and Prevention (CDC. CDC Yellow Book 2020: health information for international travel. Oxford University Press; 2019 May.
3. 3. Yamaoka Y, editor. Helicobacter pylori: molecular genetics and cellular biology. Horizon Scientific Press; 2008.
4. 4. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiologic reviews. 2000 Jan; 22(2):283-97.
5. 5. Marshall C, Baller J, Stokes S. COMMENTS OF.